CNTX icon

Context Therapeutics
CNTX

Overview Fund Activity

25 hedge funds and large institutions have $5.43M invested in Context Therapeutics in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACM
1
ADAR1 Capital Management
Texas
$284K
2
OM
2
Opaleye Management
Massachusetts
$1.53M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$30.9K
4
JFG
4
Jefferies Financial Group
New York
$15.8K
5
XT
5
XTX Topco
Cayman Islands
$14.2K

Top Sellers

1
AWM
1
Aspire Wealth Management
Massachusetts
$0
2
UBS Group
2
UBS Group
Switzerland
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$20.8K
4
TRCT
4
Tower Research Capital (TRC)
New York
$8.77K
5
Bank of America
5
Bank of America
North Carolina
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AWM
26
Aspire Wealth Management
Massachusetts
– -$11.3K -10,000 Closed
UBS Group
27
UBS Group
Switzerland
– -$10.7K -9,490 Closed
Bank of America
28
Bank of America
North Carolina
– -$123 -109 Closed
1
2